This video developed by Public Health Canada helps to educate Canadians on how vaccines are developed to ultimately instill confidence in the population to receive the COVID-19 vaccine.
This publication identifies the Public Health Agency's post-market surveillance system, which is used to monitor the safety and effectiveness of a vaccine once it is authorized for use.
This page highlights how this system has altered to address the use of COVID-19 vaccines, how the federal government is monitoring the emerging COVID-19 variants with regards to current authorized vaccines, and how to report any vaccine or treatment safety concerns to Health Canada
This document outlines the Government of Canada's approach to the COVID-19 vaccine including production, development, and securing the vaccine for Canadians.
Additionally, it discusses Health Canada's rigorous process for reviewing and authorizing COVID-19 vaccines and treatments for use in Canada.
This page examines the viral vector-based AstraZeneca COVID-19 vaccine and outlines how the ingredients, how it works, how it is administered, the possible side effects, and how the safety of the vaccine is monitored once it is given out.
This page gives information on the one-dose viral vector-based Janssen COVID-19 vaccine and highlights how it works, how it's given, the potential side effects, and the way the vaccine safety is insured once authorized.
This page discusses the Health Canada approved mRNA Moderna COVID-19 vaccine and outlines the ingredients, how it works, how it is given, some potential side effects, and how the safety of the vaccine is being ensured after administration.
This report contains the advice from the National Advisory Committee (NACI) on Immunization regarding the interval between vaccine doses.
The document highlights the how this advice has changed since they began giving advice on this topic in December 2020 and discusses the evidence that led NACI to recommend an extension of the vaccine dose interval.
This aim of this report is to provide a detailed overview of what is currently known about the COVID-19 vaccinations that are being rolled out domestically and internationally and how to approach a safe return to life prior to the pandemic.
The report provides information regarding the current efficacy of authorized vaccines along with the many scientific uncertainties that remain as a result of new variants and the short notice of the vaccine creation.
This page outlines the advice from the National Advisory Committee on Immunization that is given to the Public Health Agency of Canada regarding immunizations.
This specific report highlights advice regarding the COVID-19 vaccine in order to ensure it is distributed efficiently, effectively, and equitably throughout the country.
This page highlights Prime Minister Trudeau's investment of $23+ million in October of 2020 through the National Research Council of Canada Industrial Research Assistance Program in order to help assist the research and development of domestically made vaccines and therapeutics for COVID-19.
This page outlines the details and amount of funding given to the various vaccination and therapeutics candidates around the country.